Research Briefing from the Global Conference on Myositis (GCOM)
What’s next in myositis treatment—and what are the latest clinical trials revealing?
To kick off Myositis Awareness Month, The Myositis Association (TMA) and the Myositis Clinical Trials Consortium (MCTC) are partnering together to present this special webinar called Research Briefing from the Global Conference on Myositis (GCOM). This leading scientific conference, held every two years, convenes March of 2026 in Lisbon, Portugal, bringing together experts from around the world to share the newest advances in myositis research and care.
In this exclusive briefing hosted by TMA Executive Director Paula Eichenbrenner, four distinguished physicians will present key takeaways from the conference:
Edoardo Conticini, MD, PhD – Specialist in rheumatology, PhD in “Translational and Precision Medicine” at the University of Siena.
Iazsmin Bauer Ventura, MD – Associate Professor of Medicine, director of the Myositis Program at University of Chicago Medicine , presenting on “Novel Treatments in Myositis.”
Jisna Paul, MBBS, RhMSUS, FACR – Clinical Associate Professor of Internal Medicine and Rheumatology and Co-Director of the Myositis Clinic at The Ohio State University Wexner Medical Center (USA), co-presenting on “Updates from Recent Clinical Trials in Inflammatory Myopathies.”
Matthew Burford, MD – Clinical Assistant Professor of Neurology at The Ohio State University College of Medicine, co-presenting on “Updates from Recent Clinical Trials in Inflammatory Myopathies.”
